Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 6Recruiting 3Unknown 2Terminated 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

NET 71Endocrine 71Gastrointestinal 8CNS 4Thoracic 3Sarcoma 2Lymphoid 2Head & Neck 1Genitourinary 1Dermatologic 1Breast 1

Conditions

Lymphoma 335Precursor Cell Lymphoblastic Leukemia-Lymphoma 292Lymphoma, Large B-Cell, Diffuse 216Lymphoma, Non-Hodgkin 192Lymphoma, Follicular 172Leukemia, Lymphocytic, Chronic, B-Cell 129Lymphoma, B-Cell 123Hodgkin Disease 112Leukemia 104Recurrence 100Lymphoma, Mantle-Cell 89Burkitt Lymphoma 88Lymphoma, T-Cell, Peripheral 60Lymphoma, Extranodal NK-T-Cell 56Multiple Myeloma 53Leukemia, Myeloid, Acute 53Lymphoma, B-Cell, Marginal Zone 51Lymphoma, T-Cell 41Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 39Neoplasms 39Leukemia, B-Cell 39Lymphoma, T-Cell, Cutaneous 37Lymphoma, Large-Cell, Immunoblastic 31Myelodysplastic Syndromes 30Hematologic Neoplasms 25Mycosis Fungoides 24Lymphoma, Large-Cell, Anaplastic 24Neoplasms, Plasma Cell 23Waldenstrom Macroglobulinemia 22Immunoblastic Lymphadenopathy 22

Interventions

Fluorodeoxyglucose F18 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Neuroendocrine Tumors × Lymphoid × Clear all
NCT05396118 2024-05-14

Simultaneous Hyperpolarized [1-13C]Pyruvate and 18F-FDG PET/MRS in Cancer Patients

Rigshospitalet, Denmark

Phase 2 Unknown
15 enrolled
BreastEndocrineLymphoidNETSarcoma

Breast Neoplasms, Lymphoma, Sarcoma, Carcinoma, Neuroendocrine, Neuroendocrine Tumors

NCT05693519 2023-01-23

GICCA

Leiden University Medical Center

Unknown
2,500 enrolled
EndocrineGastrointestinalLymphoidNET

Burkitt Lymphoma, Gastrointestinal Neoplasms, Carcinoma, Hepatocellular, Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Hepatoblastoma, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡